Paper36911533
Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article).
El Sayed SM. Onco Targets Ther, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article). Papers, record 36911533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36911533
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biochemical Origin of the Warburg Effect in Light of 15 Years of Research Experience: A Novel Evidence-Based View (An Expert Opinion Article).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30631755 | NAD Metabolism in Cancer Therapeutics. | Front Oncol | 2018 | https://conductscience.org/library/papers/30631755 | PubMed |
| 2 | 27233476 | Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer. | Cancer Lett | 2016 | https://conductscience.org/library/papers/27233476 | PubMed |
| 3 | 10903432 | Nuclear activation and translocation of mitogen-activated protein kinases modulated by ethanol in embryonic liver cells. | Biochim Biophys Acta | 2000 | https://conductscience.org/library/papers/10903432 | PubMed |
| 4 | 32801756 | Analysis of Key Genes Regulating the Warburg Effect in Patients with Gastrointestinal Cancers and Selective Inhibition of This Metabolic Pathway in Liver Cancer Cells. | Onco Targets Ther | 2020 | https://conductscience.org/library/papers/32801756 | PubMed |
| 5 | 18046334 | The interplay between MYC and HIF in cancer. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/18046334 | PubMed |
| 6 | 30453040 | The roles of sirtuins family in cell metabolism during tumor development. | Semin Cancer Biol | 2019 | https://conductscience.org/library/papers/30453040 | PubMed |
| 7 | 30483808 | NADH dehydrogenase complex I is overexpressed in incipient metastatic murine colon cancer cells. | Oncol Rep | 2019 | https://conductscience.org/library/papers/30483808 | PubMed |
| 8 | 21921941 | D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate. | Cancer Gene Ther | 2012 | https://conductscience.org/library/papers/21921941 | PubMed |
| 9 | 8955077 | Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8955077 | PubMed |
| 10 | 30209241 | Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival. | EMBO J | 2018 | https://conductscience.org/library/papers/30209241 | PubMed |
| 11 | 36147606 | Al-hijamah (the triple S treatment of prophetic medicine) significantly increases CD4/CD8 ratio in thalassemic patients via increasing TAC/MDA ratio: a clinical trial. | Am J Blood Res | 2022 | https://conductscience.org/library/papers/36147606 | PubMed |
| 12 | 24635523 | Inhibition of lactate dehydrogenase activity as an approach to cancer therapy. | Future Med Chem | 2014 | https://conductscience.org/library/papers/24635523 | PubMed |
| 13 | 22802136 | D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects. | J Bioenerg Biomembr | 2012 | https://conductscience.org/library/papers/22802136 | PubMed |
| 14 | 22318356 | 3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects. | J Bioenerg Biomembr | 2012 | https://conductscience.org/library/papers/22318356 | PubMed |
| 15 | 26177608 | Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor. | Prostate | 2015 | https://conductscience.org/library/papers/26177608 | PubMed |
| 16 | 26770649 | Antioxidant, Anti-inflammatory, and Antiulcer Potential of Manuka Honey against Gastric Ulcer in Rats. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/26770649 | PubMed |
| 17 | 31678210 | Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. | Pharmacol Res | 2019 | https://conductscience.org/library/papers/31678210 | PubMed |
| 18 | 33224571 | Promising preventive and therapeutic effects of TaibUVID nutritional supplements for COVID-19 pandemic: towards better public prophylaxis and treatment (A retrospective study). | Am J Blood Res | 2020 | https://conductscience.org/library/papers/33224571 | PubMed |
| 19 | 24071366 | Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (anticancer effects of 3-bromopyruvate through antagonizing Warburg effect). | Med Hypotheses | 2013 | https://conductscience.org/library/papers/24071366 | PubMed |
| 20 | 35965961 | The Preventive and Therapeutic Effects of Ajwa Date Fruit Extract Against Acute Diclofenac Toxicity-Induced Colopathy: An Experimental Study. | Drug Des Devel Ther | 2022 | https://conductscience.org/library/papers/35965961 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42870826 | A pathomics model for predicting lactate-related prognostic risk groups and their biological mechanisms in lung adenocarcinoma. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42870826 | PubMed |
| 41129010 | Metabolic reprogramming in diabetes and other endocrine and metabolic disorders: exploring the Warburg effect, ketones, and SGLT2 inhibitors. | Rev Endocr Metab Disord | 2026 | https://conductscience.org/library/papers/41129010 | PubMed |
| 40884151 | Glucose Metabolic Reprogramming in Colorectal Cancer: From Mechanisms to Targeted Therapy Approaches. | Cancer Med | 2025 | https://conductscience.org/library/papers/40884151 | PubMed |
| 40797262 | Nonhistone lactylation: A hub for tumour metabolic reprogramming and epigenetic regulation. | J Transl Med | 2025 | https://conductscience.org/library/papers/40797262 | PubMed |
| 40093677 | Advances in imaging techniques for tumor microenvironment evaluation in hepatocellular carcinoma. | World J Gastroenterol | 2025 | https://conductscience.org/library/papers/40093677 | PubMed |
| 38668357 | Mitochondrial-Stem Cell Connection: Providing Additional Explanations for Understanding Cancer. | Metabolites | 2024 | https://conductscience.org/library/papers/38668357 | PubMed |
| 38106446 | Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/38106446 | PubMed |
| 37895863 | Synthesis and Biological Evaluation of Some New 3-Aryl-2-thioxo-2,3-dihydroquinazolin-4(1H)-ones and 3-Aryl-2-(benzylthio)quinazolin-4(3H)-ones as Antioxidants; COX-2, LDHA, α-Glucosidase and α-Amylase Inhibitors; and Anti-Colon Carcinoma and Apoptosis-Inducing Agents. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37895863 | PubMed |
| 37895015 | In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37895015 | PubMed |
| 37736537 | Therapeutic benefits of prophetic medicine remedies in treating hematological diseases (A review article). | Am J Blood Res | 2023 | https://conductscience.org/library/papers/37736537 | PubMed |
| 37727876 | Al-Hijamah (Prophetic Wet Cupping Therapy) is a Novel Adjuvant Treatment for Viral Hepatitis That Excretes Viral Particles and Excess Ferritin Percutaneously, Synergizes Pharmacotherapy, Enhances Antiviral Immunity and Helps Better HCC Prevention and Treatment: A Novel Evidence-Based Combination with Prophetic Medicine Remedies. | J Hepatocell Carcinoma | 2023 | https://conductscience.org/library/papers/37727876 | PubMed |
| 37190124 | Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190124 | PubMed |
Genes19
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36911533
GET https://conductscience.org/api/papers/v1/36911533/references?page=2